| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9073678 | Clinical Nutrition | 2005 | 8 Pages |
Abstract
Conclusion: The use of enteral formula enriched with n-3 PUFAs in the treatment of AP seems to have clinical benefits based upon the shortened time of jejunal feeding and hospital stay.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Natalia Lasztity, Jozsef Hamvas, Lajos Biró, Ãva Németh, Tamas Marosvölgyi, Tamás Decsi, Ákos Pap, Magda Antal,